Synopsis
0
VMF
0
Australia
DRUG PRODUCT COMPOSITIONS0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATE SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DRUG PRODUCT COMPOSITIONS
DOSAGE - SOLUTION;INJECTION - 100MG/10ML (10M...DOSAGE - SOLUTION;INJECTION - 100MG/10ML (10MG/ML)
USFDA APPLICATION NUMBER - 20533
DOSAGE - SOLUTION;INJECTION - 100MG/20ML (5MG...DOSAGE - SOLUTION;INJECTION - 100MG/20ML (5MG/ML)
USFDA APPLICATION NUMBER - 20533
DOSAGE - SOLUTION;INJECTION - 150MG/30ML (5MG...DOSAGE - SOLUTION;INJECTION - 150MG/30ML (5MG/ML)
USFDA APPLICATION NUMBER - 20533
DOSAGE - SOLUTION;INJECTION - 150MG/20ML (7.5...DOSAGE - SOLUTION;INJECTION - 150MG/20ML (7.5MG/ML)
USFDA APPLICATION NUMBER - 20533
DOSAGE - SOLUTION;INJECTION - 1GM/200ML (5MG/...DOSAGE - SOLUTION;INJECTION - 1GM/200ML (5MG/ML)
USFDA APPLICATION NUMBER - 20533
DOSAGE - SOLUTION;INJECTION - 200MG/20ML (10M...DOSAGE - SOLUTION;INJECTION - 200MG/20ML (10MG/ML)
USFDA APPLICATION NUMBER - 20533
DOSAGE - SOLUTION;INJECTION - 200MG/100ML (2M...DOSAGE - SOLUTION;INJECTION - 200MG/100ML (2MG/ML)
USFDA APPLICATION NUMBER - 20533
DOSAGE - SOLUTION;INJECTION - 20MG/10ML (2MG/...DOSAGE - SOLUTION;INJECTION - 20MG/10ML (2MG/ML)
USFDA APPLICATION NUMBER - 20533
DOSAGE - SOLUTION;INJECTION - 400MG/200ML (2M...DOSAGE - SOLUTION;INJECTION - 400MG/200ML (2MG/ML)
USFDA APPLICATION NUMBER - 20533
DOSAGE - SOLUTION;INJECTION - 40MG/20ML (2MG/...DOSAGE - SOLUTION;INJECTION - 40MG/20ML (2MG/ML)
USFDA APPLICATION NUMBER - 20533
DOSAGE - SOLUTION;INJECTION - 500MG/100ML (5M...DOSAGE - SOLUTION;INJECTION - 500MG/100ML (5MG/ML)
USFDA APPLICATION NUMBER - 20533
DOSAGE - SOLUTION;INJECTION - 50MG/10ML (5MG/...DOSAGE - SOLUTION;INJECTION - 50MG/10ML (5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
USFDA APPLICATION NUMBER - 20533
DOSAGE - SOLUTION;INJECTION - 75MG/10ML (7.5M...DOSAGE - SOLUTION;INJECTION - 75MG/10ML (7.5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
USFDA APPLICATION NUMBER - 20533
Related Excipient Companies
Digital Content
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
40
PharmaCompass offers a list of Ropivacaine Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Ropivacaine Hydrochloride manufacturer or Ropivacaine Hydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Ropivacaine Hydrochloride manufacturer or Ropivacaine Hydrochloride supplier.
PharmaCompass also assists you with knowing the Ropivacaine Hydrochloride API Price utilized in the formulation of products. Ropivacaine Hydrochloride API Price is not always fixed or binding as the Ropivacaine Hydrochloride Price is obtained through a variety of data sources. The Ropivacaine Hydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Ropivacaine Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ropivacaine Hydrochloride, including repackagers and relabelers. The FDA regulates Ropivacaine Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ropivacaine Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Ropivacaine Hydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Ropivacaine Hydrochloride supplier is an individual or a company that provides Ropivacaine Hydrochloride active pharmaceutical ingredient (API) or Ropivacaine Hydrochloride finished formulations upon request. The Ropivacaine Hydrochloride suppliers may include Ropivacaine Hydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Ropivacaine Hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Ropivacaine Hydrochloride DMF (Drug Master File) is a document detailing the whole manufacturing process of Ropivacaine Hydrochloride active pharmaceutical ingredient (API) in detail. Different forms of Ropivacaine Hydrochloride DMFs exist exist since differing nations have different regulations, such as Ropivacaine Hydrochloride USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Ropivacaine Hydrochloride DMF submitted to regulatory agencies in the US is known as a USDMF. Ropivacaine Hydrochloride USDMF includes data on Ropivacaine Hydrochloride's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Ropivacaine Hydrochloride USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Ropivacaine Hydrochloride suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Ropivacaine Hydrochloride Drug Master File in Japan (Ropivacaine Hydrochloride JDMF) empowers Ropivacaine Hydrochloride API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Ropivacaine Hydrochloride JDMF during the approval evaluation for pharmaceutical products. At the time of Ropivacaine Hydrochloride JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Ropivacaine Hydrochloride suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Ropivacaine Hydrochloride Drug Master File in Korea (Ropivacaine Hydrochloride KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Ropivacaine Hydrochloride. The MFDS reviews the Ropivacaine Hydrochloride KDMF as part of the drug registration process and uses the information provided in the Ropivacaine Hydrochloride KDMF to evaluate the safety and efficacy of the drug.
After submitting a Ropivacaine Hydrochloride KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Ropivacaine Hydrochloride API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Ropivacaine Hydrochloride suppliers with KDMF on PharmaCompass.
A Ropivacaine Hydrochloride CEP of the European Pharmacopoeia monograph is often referred to as a Ropivacaine Hydrochloride Certificate of Suitability (COS). The purpose of a Ropivacaine Hydrochloride CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Ropivacaine Hydrochloride EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Ropivacaine Hydrochloride to their clients by showing that a Ropivacaine Hydrochloride CEP has been issued for it. The manufacturer submits a Ropivacaine Hydrochloride CEP (COS) as part of the market authorization procedure, and it takes on the role of a Ropivacaine Hydrochloride CEP holder for the record. Additionally, the data presented in the Ropivacaine Hydrochloride CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Ropivacaine Hydrochloride DMF.
A Ropivacaine Hydrochloride CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Ropivacaine Hydrochloride CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Ropivacaine Hydrochloride suppliers with CEP (COS) on PharmaCompass.
A Ropivacaine Hydrochloride written confirmation (Ropivacaine Hydrochloride WC) is an official document issued by a regulatory agency to a Ropivacaine Hydrochloride manufacturer, verifying that the manufacturing facility of a Ropivacaine Hydrochloride active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Ropivacaine Hydrochloride APIs or Ropivacaine Hydrochloride finished pharmaceutical products to another nation, regulatory agencies frequently require a Ropivacaine Hydrochloride WC (written confirmation) as part of the regulatory process.
click here to find a list of Ropivacaine Hydrochloride suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Ropivacaine Hydrochloride as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Ropivacaine Hydrochloride API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Ropivacaine Hydrochloride as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Ropivacaine Hydrochloride and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Ropivacaine Hydrochloride NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Ropivacaine Hydrochloride suppliers with NDC on PharmaCompass.
Ropivacaine Hydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Ropivacaine Hydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Ropivacaine Hydrochloride GMP manufacturer or Ropivacaine Hydrochloride GMP API supplier for your needs.
A Ropivacaine Hydrochloride CoA (Certificate of Analysis) is a formal document that attests to Ropivacaine Hydrochloride's compliance with Ropivacaine Hydrochloride specifications and serves as a tool for batch-level quality control.
Ropivacaine Hydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each Ropivacaine Hydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Ropivacaine Hydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Ropivacaine Hydrochloride EP), Ropivacaine Hydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Ropivacaine Hydrochloride USP).
